12.2 Depressive Disorders, Bipolar and Related Disorders, and Suicide Risk

Depressive Disorders, Bipolar and Related Disorders, and Suicide Risk

Mood disorders represent severe, sustained disturbances in emotional regulation, affect, and energy that depart markedly from ordinary emotional fluctuations, generating profound psychosocial and occupational impairment. These conditions are broadly stratified into Unipolar Depressive Disorders (characterized exclusively by depressive valleys) and Bipolar and Related Disorders (characterized by cyclical transitions between depressive depths and manic or hypomanic elevations).

1. Depressive Disorders: Diagnostic Architecture and Clinical Subtypes

Depressive disorders in the DSM-5-TR encompass Major Depressive Disorder, Persistent Depressive Disorder, Premenstrual Dysphoric Disorder, and Disruptive Mood Dysregulation Disorder.

Major Depressive Disorder (MDD)

• Diagnostic Threshold: Requires the presence of at least 5 of 9 symptoms during the same 2-week period, representing an unequivocal change from previous functioning. Crucially, at least one of the symptoms must be either (1) Depressed mood or (2) Loss of interest or pleasure (anhedonia).
• The SIGECAPS Diagnostic Framework: Clinical and pedagogical practice standardizes the 9 symptoms through the SIGECAPS mnemonic:

                               [ SIGECAPS Diagnostic Criteria ]
                                              │
     ┌──────────────────┬─────────────────────┼─────────────────────┬──────────────────┐
     ▼                  ▼                     ▼                     ▼                  ▼
  [ S - Sleep ]     [ I - Interest ]      [ G - Guilt ]         [ E - Energy ]     [ C - Concentration ]
  Insomnia or       Pervasive             Worthlessness;        Persistent         Indecisiveness;
  Hypersomnia       Anhedonia             Excessive guilt       Fatigue            Executive slowing
     │                  │                     │                     │                  │
     └──────────────────┴──────────────┬──────┴─────────────────────┴──────────────────┘
                                       │
                        ┌──────────────┴──────────────┐
                        ▼                             ▼
                 [ A - Appetite ]             [ P - Psychomotor ]          [ S - Suicide ]
                 Weight/appetite              Agitation or                 Recurrent ideation,
                 fluctuation >= 5%           retardation (observable)     intent, or attempt

1. Depressed Mood: Subjective feeling of sadness, emptiness, or hopelessness most of the day, nearly every day (in children/adolescents, can manifest as irritable mood).
2. Interest Loss (Anhedonia): Markedly diminished interest or pleasure in all, or almost all, daily activities.
3. Sleep Disturbance: Insomnia (initial, middle, or terminal early morning awakening) or hypersomnia nearly every day.
4. Guilt / Worthlessness: Feelings of worthlessness or excessive, inappropriate guilt (which may be delusional) beyond mere self-reproach about being sick.
5. Energy Depletion: Fatigue or loss of energy nearly every day; minimal tasks require substantial physical and mental effort.
6. Concentration Deficits: Diminished ability to think, concentrate, process information, or marked indecisiveness.
7. Appetite / Weight Changes: Significant weight loss when not dieting or weight gain (e.g., a change of $> 5\%$ of body weight in a month), or decrease/increase in appetite nearly every day.
8. Psychomotor Changes: Psychomotor agitation (restless pacing, hand-wringing) or psychomotor retardation (slowed speech, prolonged pauses, slowed body movements) that is observable by others, not merely subjective feelings of restlessness or being slowed down.
9. Suicidal Ideation: Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide.

• Diagnostic Exclusions: Symptoms must cause clinically significant distress or functional impairment, cannot be attributable to physiological effects of a substance or medical condition, and the individual must have never met criteria for a manic or hypomanic episode (which would convert the diagnosis to Bipolar Disorder).

Clinical Specifiers for Major Depressive Disorder

• With Melancholic Features: Characterized by profound, absolute loss of pleasure in all activities, complete lack of mood reactivity to usually pleasurable stimuli, and at least three of: distinct quality of depressed mood (profound despondency), morning worsening of mood, early morning awakening (at least 2 hours before normal), marked psychomotor retardation or agitation, significant anorexia or weight loss, and excessive/inappropriate guilt. Represents a severe biological subtype responsive to pharmacotherapy and ECT.
• With Atypical Features: Displays preserved mood reactivity (mood brightens in response to actual or potential positive events) and at least two of: significant weight gain or increase in appetite, hypersomnia (sleeping $\ge 10$ hours/day), leaden paralysis (heavy, lead-like feelings in arms or legs), and long-standing pattern of interpersonal rejection sensitivity resulting in occupational or social impairment.
• With Psychotic Features: Presence of delusions and/or hallucinations during the depressive episode. Differentiated into mood-congruent (content consistent with depressive themes of personal inadequacy, guilt, death, nihilism, or deserved punishment) versus mood-incongruent (delusions/hallucinations involving persecutory or bizarre themes unrelated to depressive themes).
• With Seasonal Pattern (Seasonal Affective Disorder / SAD): Demonstrates a consistent temporal relationship between the onset of major depressive episodes and a particular time of the year (characteristically late fall or winter), with full remission occurring in spring. Mediated by phase-delayed circadian rhythms and reduced environmental light exposure; treated with early morning bright light phototherapy (10,000 lux).
• With Peripartum Onset: Symptom onset occurs during pregnancy or in the 4 weeks following delivery.

Persistent Depressive Disorder (PDD / Dysthymia)

Persistent Depressive Disorder represents a chronic, consolidation of DSM-IV dysthymic disorder and chronic major depression:

• Duration Requirement: Depressed mood for most of the day, for more days than not, for at least 2 consecutive years (in children and adolescents, mood can be irritable and duration must be at least 1 year).
• Symptom Threshold: Requires the presence of at least 2 of the following 6 symptoms while depressed:
  1. Poor appetite or overeating
  2. Insomnia or hypersomnia
  3. Low energy or fatigue
  4. Low self-esteem
  5. Poor concentration or difficulty making decisions
  6. Feelings of hopelessness
• Chronicity Parameter: During the 2-year period of disturbance, the individual has never been without symptoms for more than 2 months at a time.
• "Double Depression": A common clinical presentation wherein a patient with baseline Persistent Depressive Disorder experiences a full-blown Major Depressive Episode superimposed upon their chronic low-grade dysthymic baseline.

2. Etiological Models of Depression: Biological, Cognitive, and Behavioral

                                  [ Etiology of Depression ]
                                              │
     ┌────────────────────────────────────────┴────────────────────────────────────────┐
     ▼                                                                                 ▼
[ Biological Substrates ]                                                   [ Cognitive Formulations ]
- Monoamine Hypothesis (5-HT, NE, DA)                                      - Aaron Beck: Cognitive Triad
- BDNF / Neurogenic Hypothesis                                               (Self, World, Future)
  (Hippocampal dendritic atrophy)                                          - Cognitive Distortions
- Sleep Architecture Disturbances                                          - Seligman / Abramson:
  (Shortened REM latency < 60 min)                                           Depressive Attributional Style
                                                                             (Internal, Stable, Global)

Biological and Neurochemical Substrates

1. The Classic Monoamine Hypothesis: Formulated in the 1960s, this hypothesis posited that depression results from an absolute or functional deficit in monoamine neurotransmitters—principally serotonin (5-HT), norepinephrine (NE), and dopamine (DA)—at central synaptic clefts. While supported by the discovery that monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs) elevated monoamine levels and relieved depression, the hypothesis suffers from a profound paradox:
   • The Therapeutic Lag Paradox: Antidepressant medications (such as SSRIs) bind to presynaptic reuptake transporters and dramatically elevate synaptic monoamine concentrations within hours of administration. However, measurable clinical alleviation of depressive symptoms requires 2 to 6 weeks of continuous pharmacotherapy. This disconnect proves that simple neurotransmitter availability cannot directly explain depression.
2. The Neurogenic / BDNF Hypothesis of Depression: Contemporary neurobiology resolves the therapeutic lag by conceptualizing depression as a failure of neural plasticity and neurogenesis. Chronic psychological stress drives sustained hyperactivation of the Hypothalamic-Pituitary-Adrenal (HPA) axis, resulting in excessive circulating glucocorticoids (cortisol). Sustained glucocorticoid toxicity downregulates the expression of Brain-Derived Neurotrophic Factor (BDNF) in the hippocampus and prefrontal cortex. This causes dendritic retraction, loss of dendritic spines, and suppression of adult neurogenesis in the subgranular zone of the dentate gyrus, leading to measurable hippocampal volume loss. Sustained administration of antidepressants stimulates intracellular cyclic AMP signaling, activating the transcription factor CREB, which upregulates BDNF transcription. The 2-to-6-week delay corresponds precisely to the biological timeline required for BDNF to stimulate dendritic arborization and restore hippocampal synaptic plasticity.
3. Sleep Architecture Aberrations: Depressed individuals exhibit characteristic polysomnographic abnormalities:
   • Shortened REM Latency: The temporal interval from sleep onset to the appearance of the first REM period is drastically compressed (often $< 60$ minutes, compared to normal latency of 90–120 minutes).
   • Increased REM Density and Duration: REM sleep is pathologically concentrated in the first third of the night.
   • Reduced Slow-Wave Sleep: Profound reductions in restorative Stage 3/4 non-REM slow-wave (delta) sleep.

Cognitive and Behavioral Etiological Formulations

• Aaron Beck's Cognitive Model of Depression: Beck asserted that depression is fundamentally a disorder of cognitive processing rather than a primary affective illness. Early traumatic or invalidating developmental experiences create latent, rigid depressogenic schemas (core beliefs, e.g., "I am unlovable," "I am an absolute failure"). When activated by congruent life stressors, these schemas bias information processing through systematic cognitive distortions, giving rise to repetitive Automatic Thoughts.
  • The Negative Cognitive Triad: Beck identified three interlocking domains of negative, automatic ideation:
    1. Negative View of the Self: The individual views themselves as defective, inadequate, worthless, and psychologically flawed ("I am a failure").
    2. Negative View of the World / Ongoing Experiences: The individual interprets daily interactions and environmental events as overwhelmingly demanding, hostile, and defeating ("The world imposes impossible burdens on me").
    3. Negative View of the Future: The individual maintains the unshakeable conviction that suffering, hardship, and failure will endure indefinitely ("Nothing will ever get better").
  • Characteristic Cognitive Distortions:
    • Arbitrary Inference: Drawing a definitive negative conclusion in the absence of supporting evidence or in the face of contrary facts.
    • Selective Abstraction: Fixating exclusively on a single negative detail ripped from context while ignoring the positive whole.
    • Overgeneralization: Formulating a sweeping global conclusion based on a single isolated adverse event.
    • Dichotomous (All-or-Nothing) Thinking: Evaluating experiences in extreme, polarized categories with zero middle ground (e.g., "If I am not completely perfect, I am an utter failure").
    • Personalization: Assuming personal causal responsibility for external negative events outside one's control.
• Learned Helplessness and Reformulated Hopelessness Theory:
  • Martin Seligman's Classical Learned Helplessness (1967): In triadic shuttle-box experiments, dogs subjected to inescapable electric shocks initially struggled, but eventually adopted passive resignation. When subsequently transferred to an apparatus where shock was easily escapable by leaping over a low barrier, the dogs made no effort to escape, passively enduring the shocks. Seligman asserted that exposure to uncontrollable aversive events teaches organisms that their voluntary behaviors cannot influence environmental outcomes, producing behavioral passivity, motivational deficits, and emotional distress.
  • Abramson, Seligman, and Teasdale's Reformulated Attributional Model (1978): Cognitive reformulation demonstrated that human vulnerability to depression depends upon how individuals explain adverse life events. Depressed individuals exhibit a distinct Depressive Attributional Style (explanatory style) characterized by three orthogonal dimensions:

• Abramson, Metalsky, and Alloy's Hopelessness Theory (1989): Refined the attributional model by identifying hopelessness as a proximal, sufficient cause of depression. Hopelessness is defined as the absolute expectation that highly desired positive outcomes will not occur, paired with the belief that one is totally powerless to alter this outcome.
• Susan Nolen-Hoeksema's Response Styles Theory (Rumination): Posits that individuals who respond to depressive mood by engaging in rumination—repetitively, passively focusing on the causes, meanings, and consequences of their distress without engaging in active problem-solving—amplify, prolong, and deepen depressive episodes. Women display a significantly higher propensity for depressive rumination than men, explaining in substantial part the 2:1 female-to-male prevalence ratio in MDD.

3. Bipolar and Related Disorders: Diagnostic Spectrum and Neurobiology

Bipolar disorders represent cyclical mood conditions characterized by manic or hypomanic episodes, typically alternating with major depressive episodes. They are classified based on the severity and duration of mood elevations.

Mood Episode Definitions

                         [ Mood Episodes Stratification ]
                                        │
     ┌──────────────────────────────────┴──────────────────────────────────┐
     ▼                                                                     ▼
[ Manic Episode ]                                                 [ Hypomanic Episode ]
- Duration: >= 1 week (or any hospitalization)                     - Duration: >= 4 consecutive days
- Marked social/occupational impairment                           - Noticeable change, but NO marked impairment
- May feature psychosis or hospitalization                        - NO psychosis; NO hospitalization
- >= 3 DIGFAST symptoms (4 if irritable)                           - >= 3 DIGFAST symptoms (4 if irritable)

• Manic Episode Criteria: A distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy, lasting at least 1 week and present most of the day, nearly every day (or any duration if psychiatric hospitalization is necessary).
  • During this period, at least 3 of 7 symptoms (or 4 symptoms if mood is only irritable) must be present to a significant degree (DIGFAST mnemonic):
    1. D - Distractibility: Attention is easily drawn to unimportant or irrelevant external stimuli.
    2. I - Indiscretion / Impulsive Risk-Taking: Excessive involvement in activities that have a high potential for painful consequences (e.g., unrestrained shopping sprees, sexual indiscretions, foolish business investments).
    3. G - Grandiosity: Inflated self-esteem or grandiosity, ranging from uncritical self-confidence to grandiose delusions of special identity, divine connection, or superhuman power.
    4. F - Flight of Ideas: Subjective experience that thoughts are racing, or objective cognitive derailment and rapid shifts from topic to topic.
    5. A - Activity Increase: Markedly increased goal-directed activity (socially, at work, at school, sexually) or psychomotor agitation (purposeless non-goal-directed activity).
    6. S - Sleep Need Decreased: Feels fully rested after only 2 or 3 hours of sleep (distinguished from insomnia, where the individual craves sleep but cannot achieve it).
    7. T - Talkativeness: More talkative than usual or feels intense, unstoppable pressure to keep talking (pressured speech).
  • Severity Threshold: The mood disturbance must cause marked impairment in social or occupational functioning, OR necessitate hospitalization to prevent harm to self or others, OR involve psychotic features.
• Hypomanic Episode Criteria: A distinct period of elevated, expansive, or irritable mood and increased activity/energy lasting at least 4 consecutive days.
  • Requires the same symptom menu ($\ge 3$ DIGFAST symptoms, or 4 if irritable).
  • The Critical Boundaries: The episode is an unequivocal change in functioning observable by others, but is NOT severe enough to cause marked impairment in social or occupational functioning, does NOT require hospitalization, and by definition CANNOT possess psychotic features. (If psychotic features are present, the episode is, by diagnostic definition, Manic).

The Bipolar Diagnostic Classifications

• Rapid Cycling Specifier: Applies to Bipolar I or Bipolar II when an individual experiences at least 4 distinct mood episodes (any combination of manic, hypomanic, or major depressive episodes) within a 12-month period. More prevalent in females; associated with poorer long-term prognosis and resistance to standard lithium therapy.

Heritability and Biological Pathophysiology

• Genetic Liability: Bipolar I Disorder is among the most heritable psychiatric disorders, with twin-study heritability estimates of roughly 60% to 85%. Monozygotic (MZ) concordance is typically reported at about 40% to 70%, versus roughly 5% to 10% in dizygotic (DZ) twins. It is a polygenic condition sharing significant genetic overlap with schizophrenia (e.g., voltage-gated calcium channel subunit CACNA1C).
• Neurotransmitter Dysregulation (The Permissive Hypothesis): Formulated by Arthur Prange, the permissive serotonin hypothesis posits that low central serotonergic tone serves as a necessary biochemical precondition that "permits" affective instability:
  • Low 5-HT + Low Norepinephrine/Dopamine $\longrightarrow$ Major Depression
  • Low 5-HT + High Norepinephrine/Dopamine $\longrightarrow$ Mania
• Intracellular Signaling and Lithium: Pathophysiology involves aberrant intracellular second-messenger signaling cascades, including hyperactive protein kinase C (PKC) and overactive glycogen synthase kinase-3 (GSK-3). Lithium carbonate, the prototypical mood stabilizer, inhibits GSK-3 and depletes intracellular inositol via inositol monophosphatase inhibition, stabilizing neuronal excitability.
• Circadian and Social Rhythm Disruption: Patients with bipolar disorder possess fragile circadian pacemaker systems. Life events that disrupt regular social schedules and sleep-wake cycles (social zeitgebers) can trigger manic relapses, providing the clinical rationale for Interpersonal and Social Rhythm Therapy (IPSRT).

4. Suicide Risk Factors, Epidemiology, and Theoretical Formulations

Suicidal behavior is a complex, multidetermined public health crisis inextricably linked to severe psychopathology, particularly unipolar depression, bipolar disorder, and borderline personality disorder.

Epidemiology: The Gender Paradox in Suicide

Epidemiological surveillance across Western societies reveals a striking, consistent divergence termed the Gender Paradox of Suicidal Behavior:

• Attempt Rates: Females exhibit significantly higher rates of nonfatal suicide attempts—approximately 2 to 3 times higher than males.
• Completion Rates: Males exhibit significantly higher rates of completed, lethal suicide—approximately 3 to 4 times higher than females.
• Etiological Explanation: The primary explanatory variable accounting for this divergence is method lethality. Males disproportionately select highly lethal, irreversible means—predominantly firearms and hanging—which afford virtually zero opportunity for medical resuscitation. Females more frequently utilize potentially survivable modalities with longer therapeutic intervention windows, such as medication overdoses and poisoning.
• Age Demographics: While suicide ranks among the leading causes of death for adolescents and young adults (second for ages 10–14 and 25–34 and third for ages 15–24 in recent CDC data), the highest demographic rate of completed suicide in the United States occurs among older adult males (aged 75 and older).

Empirically Validated Clinical Risk Factors

[ Single Strongest Empirical Predictor ] ──> A History of Prior Suicide Attempts

1. Prior Suicide Attempts: A personal history of one or more prior suicide attempts constitutes the single most robust, reliable statistical predictor of eventual completed suicide.
2. Hopelessness (Aaron Beck): Pioneering psychometric research by Aaron Beck using the Beck Hopelessness Scale (BHS) demonstrated that cognitive hopelessness (pessimistic expectations regarding the future) is a vastly more accurate predictor of completed suicide than the overall severity of depressive symptoms. Patients with high depression scores but low hopelessness are at significantly lower suicide risk than patients with moderate depression and extreme hopelessness.
3. Psychiatric Comorbidity: Risk escalates exponentially when major mood disorders co-occur with Substance Use Disorders (which disinhibit impulsive behavior), Borderline Personality Disorder, or Schizophrenia.
4. Acute Warning Signs: Severe psychic agitation, intractable global insomnia, acute anhedonia, dramatic sudden brightening of mood (which may signal that an individual has finalized a suicide plan and achieved peaceful resolve), and acquiring lethal means.

Thomas Joiner's Interpersonal-Psychological Theory of Suicide (IPTS)

Thomas Joiner (2005) introduced the Interpersonal-Psychological Theory of Suicide to explain why, despite millions of individuals experiencing depressive agony and passive suicidal wishes, only a small subset make lethal suicide attempts. Joiner posited that suicidal desire alone is fundamentally insufficient; lethal suicide requires both the desire to die and the acquired physical capability to enact self-lethal violence.

              [ Thwarted Belongingness ]          [ Perceived Burdensomeness ]
              ("I am completely alone")          ("I am a liability to others")
                          │                                   │
                          └─────────────────┬─────────────────┘
                                            │
                                            ▼
                                   [ Suicidal Desire ]
                                            │
                                            ▼  +  [ Acquired Capability for Suicide ]
                                            │     (Elevated pain tolerance; fearlessness
                                            │      acquired via prior self-harm, trauma)
                                            ▼
                               [ Lethal Suicide Attempt ]

1. Thwarted Belongingness: The painful, chronic psychological state of feeling socially alienated, disconnected, and lacking meaningful, reciprocal interpersonal relationships ("I am disconnected and alone; no one cares about me").
2. Perceived Burdensomeness: The devastating, distorted conviction that one's existence is a heavy, irredeemable drain, liability, or burden on one's family, friends, or society, coupled with the belief that one's death is worth more to loved ones than one's life ("I am a burden; others would be better off if I were dead").
   • The Convergence: When Thwarted Belongingness and Perceived Burdensomeness simultaneously intersect, they generate active, potent Suicidal Desire.
3. Acquired Capability for Suicide: The evolutionary instinct of self-preservation provides a massive biological barrier against lethal self-harm. Human beings cannot enact self-directed lethal violence without overcoming the innate fear of death and physical pain. Acquired capability is an acquired, habituated physiological and psychological trait developed through repeated exposure to physically painful and fear-inducing experiences:
   • Past nonfatal suicide attempts
   • Repetitive non-suicidal self-injury (NSSI, e.g., cutting)
   • Physical abuse or chronic traumatic violence
   • Combat military exposure, contact sports, or working in emergency medical/surgical trauma settings
   • Repeated exposure habituates the individual to physical pain and extinguishes fear of bodily injury, creating the high pain tolerance and fearlessness of death required to execute a lethal act.
   • Core Postulate: A lethal or near-lethal suicide attempt occurs only when all three components converge simultaneously: Suicidal Desire (Thwarted Belongingness + Perceived Burdensomeness) alongside the Acquired Capability for Suicide.